Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.75 is 63% above its 2-year average of 2.29, near the high end of its 2-year range (0.00–3.75).
As of the fiscal period ended Tuesday, March 31, 2026. 21.16% above its 12-month average of 3.09.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2026 (2026-03-31): 3.75.
QUICK RATIO (ACID-TEST)
3.75
QUICK RATIO (ACID-TEST) AVG TTM
3.09
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+21.16%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.11
median of 688 covered companies
CURRENT VS SECTOR MEDIAN
+20.47%
vs the sector median at left
Cellyan Biotechnology Co., Ltd
Market Cap
$1.11M
Quick Ratio (Acid-Test)
3.75
TTM Avg
3.09
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.07M
Quick Ratio (Acid-Test)
4.31
TTM Avg
1.47
3Y Avg
1.08
5Y Avg
7.17
Market Cap
$1.21M
Quick Ratio (Acid-Test)
0.62
TTM Avg
1.47
3Y Avg
0.74
5Y Avg
0.53
Market Cap
$1.17M
Quick Ratio (Acid-Test)
2.55
TTM Avg
2.02
3Y Avg
1.02
5Y Avg
0.68
Market Cap
$1.02M
Quick Ratio (Acid-Test)
7.81
TTM Avg
0.12
3Y Avg
1.01
5Y Avg
1.01
Market Cap
$1.16M
Quick Ratio (Acid-Test)
0.46
TTM Avg
0.56
3Y Avg
0.51
5Y Avg
1.01
Market Cap
$851060.00
Quick Ratio (Acid-Test)
8.67
TTM Avg
12.04
3Y Avg
7.97
5Y Avg
19.74
Market Cap
$873967.00
Quick Ratio (Acid-Test)
0.46
TTM Avg
3.06
3Y Avg
2.92
5Y Avg
4.33
Market Cap
$856468.00
Quick Ratio (Acid-Test)
1.83
TTM Avg
2.05
3Y Avg
3.13
5Y Avg
5.42
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.11M | 3.75 | 3.09 | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.07M | 4.31 | 1.47 | 1.08 | 7.17 |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.21M | 0.62 | 1.47 | 0.74 | 0.53 |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.17M | 2.55 | 2.02 | 1.02 | 0.68 |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 7.81 | 0.12 | 1.01 | 1.01 |
| IM Cannabis Corp. (IMCC)vs › | $1.16M | 0.46 | 0.56 | 0.51 | 1.01 |
| Bone Biologics Corporation (BBLG)vs › | $851060.00 | 8.67 | 12.04 | 7.97 | 19.74 |
| GlucoTrack, Inc. (GCTK)vs › | $873967.00 | 0.46 | 3.06 | 2.92 | 4.33 |
| Decoy Therapeutics Inc. (DCOY)vs › | $856468.00 | 1.83 | 2.05 | 3.13 | 5.42 |
| Genprex, Inc. (GNPX)vs › | $1.37M | 6.77 | 2.33 | 3.65 | 16.80 |
Quick Ratio
3.75
Excludes inventory
Current Ratio
3.86
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 3.75 |
| 2025-09-30 | 2.73 |
| 2025-03-31 | 2.80 |
| 2024-09-30 | 2.31 |
| 2024-03-31 | 2.16 |
| 2023-09-30 | 0.00 |
